Kassberg Thomas Richard
Reporting Owner SEC Filing List
CIK: 0001303811
| Form | Filer | Subject Company | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Passage Bio, Inc. | Sec Connect /fa | 05/30/2025 | |||
| 4 | Statement of changes in beneficial owner... | Kassberg Thomas Richard | Sec Connect /fa | 05/30/2025 | |||
| 4 | Statement of changes in beneficial owner... | Ultragenyx Pharmaceutical Inc. | Donnelley Financial Solutions /fa | 03/04/2025 | |||
| 4 | Statement of changes in beneficial owner... | Kassberg Thomas Richard | Donnelley Financial Solutions /fa | 03/04/2025 | |||
| 3 | Initial statement of beneficial ownershi... | Kassberg Thomas Richard | Sec Connect /fa | 10/02/2024 | |||
| 4 | Statement of changes in beneficial owner... | Kassberg Thomas Richard | Sec Connect /fa | 10/02/2024 | |||
| 3 | Initial statement of beneficial ownershi... | Passage Bio, Inc. | Sec Connect /fa | 10/02/2024 | |||
| 4 | Statement of changes in beneficial owner... | Passage Bio, Inc. | Sec Connect /fa | 10/02/2024 | |||
| 4 | Statement of changes in beneficial owner... | Ultragenyx Pharmaceutical Inc. | Donnelley Financial Solutions /fa | 03/12/2024 | |||
| 4 | Statement of changes in beneficial owner... | Kassberg Thomas Richard | Donnelley Financial Solutions /fa | 03/12/2024 | |||
| Load More | |||||||
Kassberg Thomas Richard 's Ownership Transactions
| Issuer | Filing Date | Transaction Date | Transaction Type | Shares | Price | Total Amt | Shares Owned |
|---|
